Vimarsana
Biggest News Aggregation in the World

Page 26 - Iontech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iontech Today - Breaking & Trending Today

A two-step plan to drag Hong Kong out of its Covid-19 rut - Vimarsana News

A two-step plan to drag Hong Kong out of its Covid-19 rut

Given the billions the government is spending on consumption vouchers and free airline tickets, it can pay seniors to get triple-vaccinated, which could save their lives. After doing so, it should scrap all other restrictions, thus safeguarding the economy and people’s sanity.

Source: scmp.com
Cancer vaccine could be available by 2030 - Vimarsana News

Cancer vaccine could be available by 2030

German couple Professors Ugur Sahin and Ozlem Tureci said they have had ‘breakthroughs’ they will keep working on.

Source: aol.com
Pfizer- BioNTech Early Study Data For Omicron BA.4/BA.5-Adapted Bivalent Booster Vaccine, Positive - Vimarsana News

Pfizer- BioNTech Early Study Data For Omicron BA.4/BA.5-Adapted Bivalent Booster Vaccine, Positive

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and BioNTech SE (BNTX) Thursday announced positive early data from the Phase 2/3 study of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine booster

Pfizer Inc.: Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age - Vimarsana News

Pfizer Inc.: Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for a 10-µg booster dose of their Omicron

Straight to the point: the Post examines second- generation coronavirus jabs that could be used in Hong Kong - Vimarsana News

Straight to the point: the Post examines second- generation coronavirus jabs that could be used in Hong Kong

City officials examining application for approval of second-generation BioNTech coronavirus vaccine designed to target Omicron variant.

Source: scmp.com
Related Topics:
Hong Kong